152 related articles for article (PubMed ID: 4309930)
1. [Immunological aspects of multiple sclerosis].
Bakouche P
Munch Med Wochenschr; 1969 Sep; 111(39):1985-7. PubMed ID: 4309930
[No Abstract] [Full Text] [Related]
2. Cellular immunity in multiple sclerosis. Implications for pathogenesis and treatment.
Thompson RF; Davenport J
Mo Med; 1984 Oct; 81(10):669-73. PubMed ID: 6092887
[No Abstract] [Full Text] [Related]
3. [Cyclophosphamide in the therapy of multiple sclerosis].
Salvatores U; Majeron M; Mascetti A
Riv Sper Freniatr Med Leg Alien Ment; 1972 Feb; 96(1):163-84. PubMed ID: 4337775
[No Abstract] [Full Text] [Related]
4. [Immunological aspects of multiple sclerosis].
Bakouche P
Rev Clin Esp; 1969 Dec; 115(6):521-4. PubMed ID: 5405739
[No Abstract] [Full Text] [Related]
5. [Immunosuppressive treatment im multiple sclerosis].
Mertin J
Fortschr Med; 1980 Oct; 98(37):1431-6. PubMed ID: 6253370
[TBL] [Abstract][Full Text] [Related]
6. [Abnormalities in the immune system of MS patients and possibilities of immunological treatment].
Salonen R; Ilonen J
Duodecim; 1992; 108(1):82-92. PubMed ID: 1365988
[No Abstract] [Full Text] [Related]
7. [Present possibilities in the therapy of multiple sclerosis].
Jedlicka P
Cesk Neurol Neurochir; 1987 Jul; 50(4):209-17. PubMed ID: 2822262
[No Abstract] [Full Text] [Related]
8. [Various immunological aspects of demyelinations. II. Attempts at the determination of immunological reactions in multiple sclerosis].
Vymazal J; Krásenská-Dlabacová J
Cesk Neurol Neurochir; 1974 Jul; 37(4):240-6. PubMed ID: 4846373
[No Abstract] [Full Text] [Related]
9. [Multiple sclerosis].
Steck AJ
Rev Med Suisse Romande; 1984 Mar; 104(3):231-8. PubMed ID: 6326241
[No Abstract] [Full Text] [Related]
10. [Review of the therapy of multiple sclerosis].
De Rosa A; Puccini A; De Martino V
Recenti Prog Med; 1982 Dec; 73(6):651-68. PubMed ID: 6308734
[No Abstract] [Full Text] [Related]
11. Multiple sclerosis: pilot therapeutic trial of immunosuppressants.
Cendrowski WS
Schweiz Arch Neurol Neurochir Psychiatr; 1969; 105(2):241-6. PubMed ID: 4314087
[No Abstract] [Full Text] [Related]
12. Medications used in the treatment of multiple sclerosis.
Schapiro RT
Phys Med Rehabil Clin N Am; 1999 May; 10(2):437-46, ix. PubMed ID: 10370939
[TBL] [Abstract][Full Text] [Related]
13. [Immunologic aspects of disseminated sclerosis].
Bakouche P
Cah Coll Med Hop Paris; 1969 Oct; 10(12):1011-3. PubMed ID: 5366946
[No Abstract] [Full Text] [Related]
14. [Destruction of neurons cultivated in vitro by lymphocytes from patients with multiple sclerosis].
Halpern B; Bakouche P; Martial-Lasgargues C
Bull Acad Natl Med; 1969; 153(13):232-7. PubMed ID: 4901670
[No Abstract] [Full Text] [Related]
15. [Destruction of nerve cells cultured "in vitro" by lymphocytes from patients with multiple sclerosis. Auto-immune pathogenesis of multiple sclerosis].
Halpern B; Bakouche P; Martial-Lasfargues C
Presse Med (1893); 1969 Dec; 77(55):2103-6. PubMed ID: 4190510
[No Abstract] [Full Text] [Related]
16. Treatment and prevention of myelin disorders: multiple sclerosis.
Abramsky O
Bull Soc Belge Ophtalmol; 1983 Nov; 208 Pt 1():489-92. PubMed ID: 6326915
[No Abstract] [Full Text] [Related]
17. [Recent notions concerning the treatments used in multiple sclerosis (author's transl)].
Gonsette RE
J Belge Med Phys Rehabil; 1978; 1(3):213-6. PubMed ID: 231031
[No Abstract] [Full Text] [Related]
18. Immunosuppressive treatment of multiple sclerosis.
Hadaway LC
NITA; 1985; 8(6):503-5. PubMed ID: 2999647
[No Abstract] [Full Text] [Related]
19. [Immunological aspects of multiple sclerosis].
Bakouche P
Minerva Med; 1969 Nov; 60(94):4708-10. PubMed ID: 4187876
[No Abstract] [Full Text] [Related]
20. [Therapy of multiple sclerosis].
Kesselring J
Schweiz Med Wochenschr; 1984 Sep; 114(35):1186-90. PubMed ID: 6091263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
